Skip to main content
. 2016 Mar 27;8(3):238–245. doi: 10.4240/wjgs.v8.i3.238

Table 3.

Results after primary revision at last follow-up (n = 152)

Re-VBG n = 21 Mean ± SD cSG n = 16 Mean ± SD cRYGB n = 115 Mean ± SD Corrected P value
Re-VBG vs cSG cRYGB vs Re-VBG cRYGB vs cSG
Follow-up (mo) 39.1 ± 48.7 49.3 ± 17.6 50.0 ± 33.3
Average %EWL after VBG (%) 61.7 ± 27.0 38.7 ± 22.9 43.5 ± 25.0
Additional %EWL -14.6 ± 19.9 17.9 ± 32.7
Total %EWL (%) 45.4 ± 25.5 56.6 ± 24.4 71.7 ± 23.8 0.614 0.006 0.025
Total body weight loss (%) 18.4 ± 11.1 24.1 ± 11.6 30.4 ± 10.1 0.049 < 0.001 0.016
Change body mass index (kg/m2) 8.1 ± 5.8 10.8 ± 5.8 13.5 ± 5.1 0.119 < 0.001 0.042
Reinhold (%EWL > 50%) (%) 47.6 56.3 82.6 0.7911 (0.211; 2.972) 0.3421 (0.125; 0.934) 0.2711 (0.090; 0.812)
Long-term complications (%) 61.9 62.5 15.7 0.8331 (0.214; 3.244) 10.1051 (3.600; 28.367) 8.4211 (2.733; 25.950)
2nd revisional procedure (n, %) 10 (47.6%) 5 (31.3%) 1 (0.9%) NA NA NA
Improvement/ resolution in patients with 1 or more comorbidities (%) 80 (8/10) 60 (3/5) 92.7 (38/41) 0.3751 (0.081; 1.738) 1.2471 (0.476; 3.265) 0.4681 (0.126; 1.740)
1

Odds ratio (95%CI). Re-VBG: Revision of the vertical banded gastroplasty; cSG: Conversion to sleeve gastrectomy; cRYGB: Conversion to Roux-en-Y gastric bypass; %EWL: Excess weight loss; NA: Not available. P value is corrected for operative time, time between VBG and revision, osteo-articular disease and mean %EWL after VBG. No correction possible in logistic regression analysis due to limited events and group sizes. In case of a second revisional procedure, follow-up until second was taken into account.